MedAdvisor Ltd (ASX: MDR) Share Price and News

Price

$0.10

Movement

0.006 (+6.38%)

as at 6 May - Closed (20 mins delayed)

52 Week Range

$0.083 - $0.59

 
1 Year Return

-67.74%

MedAdvisor Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $56.19 million
P/E Ratio 107.69
Dividend Yield 0.00%
Shares Outstanding 597.72 million
Earnings per share -0.009
Dividend per share N/A
Year To Date Return -57.33%
Earnings Yield 0.93%
Franking -
Share Price

$0.10

Day Change

0.006 (+6.38%)

52 Week Range

$0.083 - $0.59

Yesterday's Close

$0.094

Today's Open

$0.095

Days Range

$0.095 - $0.10

Volume

319,382

Avg. Volume (1 month)

582,689

Turnover

$31,581

as at 6 May - Closed

  • MedAdvisor Ltd (ASX: MDR)
    Latest News

    a smiling doctor looks at her computer screen with medical imaging X-rays on a light screen in the background.
    Share Gainers

    Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday

    The MedAdvisor Ltd (ASX:MDR) share price was a strong performer on Friday and jumped as much as 9% higher. Here's…

    Read more »

    Share Market News

    MedAdvisor Ltd (ASX:MDR) share price halted ahead of transformational $49 million acquisition

    The MedAdvisor Ltd (ASX:MDR) share price is in a trading halt as it prepares to make a transformation acquisition...

    Read more »

    Digitised heart rate and share price chart with man on ipad in background signifying share price
    Speculative

    3 small cap ASX healthcare shares to watch closely in the 2020s

    Here's why I think Volpara Health Technologies Ltd (ASX:VHT) and these ASX small cap healthcare shares are worth watching...

    Read more »

    CSL share price Digitised bubbles of cells representing ASX biotech shares such as CSL
    Share Market News

    Add these 3 ASX medical technology companies to your watch list

    The global medical technology industry is worth some US$430 billion. These 3 ASX medical technology companies have promising futures.

    Read more »

    Speculative

    3 exciting small cap ASX healthcare shares to watch

    Could these small cap ASX healthcare shares be the next Ramsay Health Care Limited (ASX:RHC) and Cochlear Limited (ASX:COH)?

    Read more »

    Speculative

    3 exciting small cap ASX shares to watch very closely

    Medadvisor Ltd (ASX:MDR) and these small cap ASX shares could be destined for big things in the future. Here's why I…

    Read more »

    Speculative

    3 exciting small cap ASX healthcare shares to watch

    Volpara Health Technologies Ltd (ASX:VHT) and these small cap ASX healthcare shares could be worth adding to your watchlist...

    Read more »

    Speculative

    3 exciting ASX healthcare shares to watch in the 2020s

    Volpara Health Technologies Ltd (ASX:VHT) and these small cap ASX shares are making waves in the healthcare sector and need to…

    Read more »

    ASX Shares

    3 small cap ASX healthcare shares with enormous potential

    Could these small cap ASX healthcare shares be the next Cochlear Limited (ASX:COH) and Ramsay Health Care Limited (ASX:RHC)?

    Read more »

    a woman
    Coronavirus News

    Coronavirus: This ASX tech share is rocketing higher after telehealth launch

    The MedAdvisor Ltd (ASX:MDR) share price is rocketing higher after announcing the launch of a telehealth service to combat the…

    Read more »

    a woman
    Coronavirus News

    Why this ASX medical tech share is up 22% today

    The Medadvisor Ltd (ASX: MDR) share price has soared today after the ASX medical technology company announced it was launching…

    Read more »

    a woman
    Share Market News

    Why this ASX medical technology share surged 43% higher today

    The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role…

    Read more »

    MDR ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    2nd May 2025 2025-05-02T17:58:18 Reinstatement to Official QuotationYesNo5:58pm1105k
    2nd May 2025 2025-05-02T17:58:13 Court Orders Granted & Trading to ResumeYesNo5:58pm4206k
    1st May 2025 2025-05-01T10:33:15 Notification regarding unquoted securities - MDRYesNo10:33am718k
    30th Apr 2025 2025-04-30T09:54:28 MDR 3Q FY25 PresentationYesNo9:54am10795k
    30th Apr 2025 2025-04-30T09:54:23 MDR 3Q FY25 4C and Quarterly Activity ReportYesNo9:54am11741k
    29th Apr 2025 2025-04-29T10:14:42 MedAdvisor Solutions 3Q FY25 Investor WebinarYesNo10:14am155k
    29th Apr 2025 2025-04-29T09:45:17 Suspension from QuotationYesNo9:45am3141k
    28th Apr 2025 2025-04-28T15:40:52 Extension of MDR Share Purchase PlanYesNo3:40pm259k
    23rd Apr 2025 2025-04-23T19:20:09 Trading HaltYesNo7:20pm2163k
    23rd Apr 2025 2025-04-23T10:34:26 Cleansing noticeYesNo10:34am263k

    About MedAdvisor Ltd

    MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.

    MDR Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    05 May 2025 $0.09 $0.00 0.00% 1,923,275 $0.10 $0.10 $0.09
    23 Apr 2025 $0.10 $0.00 0.00% 426,073 $0.09 $0.10 $0.09
    22 Apr 2025 $0.09 $0.00 0.00% 298,182 $0.10 $0.10 $0.09
    17 Apr 2025 $0.09 $0.00 0.00% 304,842 $0.10 $0.10 $0.09
    16 Apr 2025 $0.10 $0.00 0.00% 10,165 $0.10 $0.10 $0.10
    15 Apr 2025 $0.09 $0.00 0.00% 667,997 $0.09 $0.09 $0.09
    14 Apr 2025 $0.09 $0.00 0.00% 1,590,789 $0.09 $0.09 $0.09
    11 Apr 2025 $0.09 $0.00 0.00% 771,473 $0.09 $0.09 $0.09
    10 Apr 2025 $0.09 $0.00 0.00% 992,053 $0.10 $0.10 $0.09
    09 Apr 2025 $0.09 $0.00 0.00% 163,023 $0.10 $0.10 $0.09
    08 Apr 2025 $0.10 $0.01 11.90% 572,567 $0.09 $0.10 $0.09

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    14 Nov 2024 Richard (Rick) Ratliff Issued 760,059 $220,417
    Issue of options.
    30 Oct 2024 Lucas Merrow Expiry 750,000 $262,500
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catherine (Kate) Jane Hill Non-Executive Director May 2023
    Ms Hill is auditor and business advisor with over 30 years of experience of working with privately owned and ASX-listed companies across a range of business issues. A former senior partner and first female board member of top 4 accounting firm Deloitte, she has in recent years turned her focus, her energies, and experience into Non-Executive Director roles. She is a director of small to mid-cap companies listed on ASX and other global exchanges, with a track record in change involving new business models, new markets, and new technologies. She is chair of Risk Committee and member of People Committee.
    Mr Jim Xenos Non-Executive Director Nov 2015
    Mr Xenos is currently the Chief Executive Officer of NostraData Pty Limited, which he co-founded in 2010. Prior to co-founding NostraData, Jim held several Associate Director positions with GlaxoSmithKline PLC. Jim was also the Head of Retail at Sigma Healthcare Limited for Herron Pharmaceuticals. She is Chair of people committee.
    Mr Lucas Merrow Non-Executive Director Aug 2021
    Mr Merrow co-founded and served as the Chief Executive Officer of Eliza Corporation-the leader in health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the Chief Operating Officer of Adheris Health, a leading firm in prescription adherence and patient education programs in the United States. MedAdvisor acquired Adheris Health in November 2020. He is Member of People Committee.
    Mr Richard (Rick) Ratliff Chief Executive OfficerManaging Director Jul 2022
    Mr Ratliff spent over 30 years in the healthcare and pharmaceutical technology sector in key markets in which MedAdvisor Solutions operates. He has led the development of several large-scale technology-enabled healthcare businesses within global organizations such as IBM and Accenture as well as via start-up and early-stage businesses, including Healthvision, Surescripts, and ConnectiveRx. Rick also worked with the Australian federal government to develop and deliver My Health Record, the leading online EHR available to all Australian citizens. He is a member of People Committee.
    Mr Kevin Hutchinson Non-Executive Director Nov 2022
    Mr Hutchinson is an entrepreneur with 30 years of experience in the tech industry. He has built and grown companies that deliver innovative services by using disruptive technology. He also has seen great success in his ability to accelerate growth by hiring and developing teams that drive exceptional results. He has served in numerous C-level executive roles, including CEO and COO, as well as several non-executive board appointments. Kevin is CEO and Director of AXL Health and on the Board of Matrix Analytics dba eon Health. He is a member of Risk Committee.
    Ms Gillian Maria Nairn Joint Company Secretary Dec 2024
    -
    Ms Ancila Desai Chief Financial OfficerCompany Secretary Feb 2023
    -
    Ancila Desai Chief Financial OfficerCompany Secretary
    -
    Gillian Maria Nairn Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Guild Group Holdings Limited 94,905,130 17.21%
    HSBC Custody Nominees (Australia) Limited 84,152,463 15.26%
    Ebos Ph Pty Ltd 53,986,823 9.79%
    J P Morgan Nominees Australia Pty Limited 45,226,380 8.20%
    Cotiviti Inc 43,999,999 7.98%
    Citicorp Nominees Pty Limited 38,361,455 6.96%
    National Nominees Limited 14,892,708 2.70%
    UBS Nominees Pty Ltd 14,289,149 2.59%
    Bond Street Custodians Limited <Salter - D79836 A/C> 9,700,000 1.76%
    Kojent Pty Ltd <Kojent A/C> 6,846,956 1.24%
    Indcorp Consulting Group Pty Limited <Superannuation Fund A/C> 6,550,000 1.19%
    Romida Enterprises Pty Ltd <Romida Family A/C> 5,642,935 1.02%
    Gread Management Pty Limited <The A G & R R Family A/C> 5,344,283 0.97%
    Provare Pty Ltd <Provare Investment A/C> 3,743,419 0.68%
    Tagdime Pty Ltd <Ian M Davison P/L S/F A/C> 3,264,316 0.59%
    Dr Christopher Harold Benton 3,000,000 0.54%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 2,815,940 0.51%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,383,158 0.43%
    Dmx Capital Partners Limited 2,351,551 0.43%
    Wavey Industries Pty Ltd <Josh Swinnerton Family A/C> 2,300,000 0.44%

    Profile

    since

    Note